Fig. 3. Frequency distributions of predicted risks of an individual whether prescribed with clozapine (true or false) of the baseline, 12-, 24- and 36-month probability classification models.

As the predicted risk increases from 0.10 or higher, there is a proportional increase in the number of individuals with clozapine use compared to those without in each subsequent risk class.